Home > Press > Applied Nanotech Announces Continuation of Research Agreement With Prominent Chemical Company
Abstract:
Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced it has entered into a continuation of its research and development agreement with a leading industrial chemical products company in Japan for manufacturing and commercializing nano-copper inks and pastes. This follows the exclusive licensing agreement signed in July 2009 with this same prominent chemical company (see press release dated July 9, 2009). The new research and development agreement, the fourth phase of the project, is effective October 1, 2009 and covers a six-month period. Applied Nanotech will receive a minimum of $300,000 in funding this phase.
This extended project, which began in October 2006, is located at ANI's facility in Austin, Texas, where ANI is providing a team of researchers, laboratory space, and equipment. This project has resulted in the previously mentioned exclusive agreement. This next phase of the project will focus on finalizing the technology transfer, personnel training, and the development of applications for copper nanoparticle inks and pastes with potential customers.
"Together with our strategic partner, we are moving closer to the commercialization of our copper nanoparticle inks and pastes," said Dr. Zvi Yaniv, CEO of Applied Nanotech, Inc. "As the efforts of our partner in Japan are focused on both manufacturing and development of applications, it is our commitment to continue supporting research and development that will accelerate the introduction of products and applications."
"We are pleased to assist our partner in their commercialization effort," said Doug Baker, CEO of APNT. "This strong collaboration is indicative of our mission to monetize technology."
####
About Applied Nanotech Holdings, Inc.
Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 250 patents or patents pending. APNT also possesses investments related to electronic digitized sign technology.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2008, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.
For more information, please click here
Contacts:
Doug Baker
Applied Nanotech Holdings, Inc.
248.391.0612
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
Research partnerships
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
Printing/Lithography/Inkjet/Inks/Bio-printing/Dyes
Presenting: Ultrasound-based printing of 3D materials—potentially inside the body December 8th, 2023
Simple ballpoint pen can write custom LEDs August 11th, 2023
Disposable electronics on a simple sheet of paper October 7th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||